The market for data analytics software is rising and so is the competition between Tableau Software and Qlik Technologies, its leading players. Demand for data analytics has escalated as companies wrestle for the best way to manage Big Data — the ever-growing volume of data coming from a variety of sources that include smartphones, wearable devices and home appliances. Tableau Software (DATA) is the No. 1 provider of this software and boasts
Big-cap biotech Alexion Pharmaceuticals on Wednesday agreed to pay $8.4 billion in cash and stock for fellow rare-disease specialist Synageva BioPharma, a price that investors greeted with trepidation. Alexion’s stock fell 8% to close at 155.01, while Synageva’s soared 112% to 203.39. Alexion (ALXN) agreed to pay $115 in cash and 0.6581 Alexion share for every Synageva (GEVA) share, which at Alexion’s nine-day volume-weighted average closing price
Generic-drug giant Mylan delivered a mixed first-quarter report late Tuesday after three other top-rated medical stocks issued more positive reports earlier in the day. Its shares slipped a fraction in after-hours trading. Mylan’s (MYL) profit rose 6% over the year-earlier quarter to 70 cents a share, beating analysts’ consensus by a penny, according to Thomson Reuters. Sales increased 9% to $1.87 billion, missing Wall Street’s number by around